by Medicine by Design | Aug 6, 2024
CCRM, the publisher of Signals, has enhanced its long-standing relationship with the University of Toronto’s Medicine by Design through a new strategic alliance. This profile is one in a series of profiles that feature “people” of Medicine by Design. Some minor edits...
by Jovana Drinjakovic | Jun 15, 2018
Plagued by failures of early human studies from the 1990s, including the death of a patient, gene therapy is making a comeback with promising results. And it has a tiny virus to thank. After the first 2012 European gene therapy approval for a liver disease, and last...
by Jovana Drinjakovic | Jan 16, 2017
Markus Grompe certainly thinks so and is working hard to make it happen. A scientist and a pediatrician specializing in inborn liver diseases, Dr. Grompe has a plan for overcoming the shortage of organ donors—the key obstacle for patients for whom the liver transplant...
by Ben Paylor | Aug 10, 2011
Did I request thee, Maker, from my clay To mould me man? Did I solicit thee From darkness to promote me? – Paradise Lost, Milton This harrowing quote from Milton, if framed as a first-person narrative of a stem cell’s fate, paints a troubling (and highly...
Comments